- Report
- January 2022
- 60 Pages
Global
From €3777EUR$3,950USD£3,161GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1195EUR$1,250USD£1,000GBP
Diabetic cardiomyopathy is a type of heart disease that is caused by long-term diabetes. It is characterized by a thickening of the heart muscle, which can lead to heart failure. Endocrine and metabolic disorders drugs are used to treat this condition, as well as other endocrine and metabolic disorders. These drugs work by controlling blood sugar levels, reducing inflammation, and improving the functioning of the heart. They can also help to reduce the risk of complications associated with diabetes, such as stroke and heart attack. Common drugs used to treat diabetic cardiomyopathy include ACE inhibitors, beta blockers, and diuretics.
Some companies in the market include Novo Nordisk, Sanofi, Merck, and Pfizer. Show Less Read more